AMAG Updates Feraheme Label To Include Safety Risks
The FDA signed off on AMAG's new product label for Feraheme on Nov. 24, AMAG said Monday.
Feraheme, AMAG's brand name for ferumoxytol, is an injection used to treat anemia in patients with chronic kidney disease. The company had been negotiating with the FDA over safety concerns in the wake...
To view the full article, register now.